Disease-modifying antirheumatic drugs comprise a category of otherwise unrelated disease-modifying drugs defined by their use in rheumatoid arthritis to slow down disease progression. From Wikipedia
Early detection of axial spondyloarthritis (axSpA) is crucial for managing symptoms and preventing progression to more severe stages.
